not only in patients at risk (with a history of inflammatory periodontal
diseases), but also in other
Xu, Dongxiao,
Zheng, Bingjie,
Wu, Qiaowei,
Yao, Jinbiao,
Ilyasova, Tatiana,
Beilerli, Aferinc,
Shi, Huaizhang (2022) disease, however, the existing methods are accompanied by a variety of complications. In this study